Molecular mechanism differences between nanoplastics and microplastics in colon toxicity: nanoplastics induce ferroptosis-mediated immunogenic cell death, while microplastics cause cell metabolic reprogramming

Yixian Cheng, Junjie Chen, Rui Fu, Peng Zhang, Haosong Chen, Haikun Cao, Zilong Jiang, Yuan Hong, Yifan Li, Cuiqi He, Tao Feng, Ting Li, Jiawei Zhang, Bo Chen, Guodong CaoJournal of Nanobiotechnology 2025 · DOI

TL;DR

This study reveals that the size of plastic particles dramatically alters their toxicological mechanisms in the gut. Nanoplastics (100 nm) induce cell death via ferroptosis, triggering an immune response, while microplastics (10 µm) cause damage through mechanical disruption and metabolic reprogramming. These findings highlight the critical role of particle size in microplastic toxicity and suggest targeted therapeutic strategies.

What Problem Does This Paper Address?

The pervasive accumulation of plastic waste, particularly microplastics (MPs) and nanoplastics (NPs), in the environment has raised significant concerns about their potential impact on human health. While MPs and NPs are known to enter the gastrointestinal tract, the specific molecular mechanisms by which they cause intestinal damage have remained unclear, especially concerning the influence of particle size. Previous research has often focused on a single particle type or size, leaving a gap in understanding how different sizes might elicit distinct toxicological responses. This paper aims to bridge this gap by directly comparing the effects of nanoscale (100 nm) and microscale (10 µm) polystyrene particles on intestinal epithelial cells and in vivo models, seeking to elucidate the size-dependent mechanisms of toxicity.

Methods

The researchers employed a multi-pronged approach combining in vitro and in vivo studies.

  • Cellular Models: Human colonic epithelial cells (NCM460) were used to investigate particle uptake, cytotoxicity (CCK-8 assay), apoptosis (Annexin V-FITC flow cytometry), and cell viability (Calcein-AM/PI staining).
  • Molecular Mechanisms: Proteomics sequencing was a key technique to identify differential gene expression between nanoplastic and microplastic exposures. This was complemented by Western blotting to confirm protein expression levels of key molecules involved in ferroptosis (e.g., Gpx4, Slc7a11) and apoptosis.
  • Biochemical Assays: Assays for reactive oxygen species (ROS), mitochondrial membrane potential (JC-1 staining), malondialdehyde (MDA), and glutathione (GSH) were performed to assess cellular stress and ferroptosis markers.
  • Signaling Pathway Analysis: Dual-luciferase reporter assays and ChIP-qPCR were used to investigate the regulatory role of Fosl1 on p53 transcription. Immunofluorescence and Western blotting were employed to study the mechanosensitive YAP pathway.
  • In Vivo Models: BALB/c mice were used to study the long-term effects of microplastic exposure. This involved monitoring body weight, Disease Activity Index (DAI), colon weight and length, and performing histological analysis (H&E staining) and ELISA for inflammatory cytokines.
  • Intervention Studies: The study utilized specific inhibitors: Ferrostatin-1 (a ferroptosis inhibitor) and Verteporfin (VTPF, a YAP inhibitor) to validate the proposed mechanisms.
  • Metabolomics: Non-targeted energy metabolomics was conducted on colon tissues to analyze metabolic reprogramming.
  • Advanced Imaging: Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM), and Atomic Force Microscopy (AFM) were used for particle characterization and to assess cellular structural changes.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Size Matters Dramatically: The most striking insight is how drastically particle size dictates the toxicological pathway. This isn't just a matter of degree; it's a fundamental shift in the cellular response.
  • Nanoplastics Trigger Ferroptosis and Immune Danger Signals: Nanoplastics, due to their ability to be internalized, initiate a cascade leading to ferroptosis. This specific type of programmed cell death releases danger signals that alert the immune system, leading to immunogenic cell death (ICD). This is a critical link between particle toxicity and immune activation.
  • Microplastics Act as Mechanical Insults: Larger microplastics, unable to enter cells easily, exert their damage through physical means. This mechanical stress activates the YAP pathway, a key regulator of cell mechanics, which then drives metabolic reprogramming.
  • Fosl1 as a Key Regulator of Nanoplastic Ferroptosis: The identification of Fosl1 as a crucial regulator that promotes p53 transcription and contributes to ferroptosis provides a specific molecular target for nanoplastic toxicity.
  • YAP as a Central Player in Microplastic Metabolic Shift: The study strongly implicates YAP in mediating the metabolic reprogramming induced by microplastics, shifting cells towards anaerobic glycolysis. This highlights YAP as a potential therapeutic target for microplastic-induced damage.
  • Distinct Therapeutic Targets: The distinct mechanisms suggest that interventions for nanoplastic and microplastic toxicity might need to be different, with ferroptosis inhibitors for NPs and YAP inhibitors for MPs.

Key Results

  • Particle Uptake: 100 nm and 500 nm polystyrene particles were readily internalized by NCM460 cells, while 1 µm and 5 µm particles showed minimal uptake, and 10 µm particles were not internalized.
  • Nanoplastic Toxicity: 100 nm NPs induced ferroptosis, characterized by increased ROS, decreased GSH, GPX4 inactivation, and lipid peroxidation. This was linked to upregulation of Fosl1 and p53 pathway genes.
  • Microplastic Toxicity: 10 µm MPs caused mechanical damage, leading to YAP activation, cytoskeletal remodeling, and a shift from oxidative phosphorylation to anaerobic glycolysis.
  • In Vivo Inflammation: Long-term exposure to MPs induced colon inflammation in mice, with smaller NPs showing more pronounced effects on body weight and colon parameters.
  • Ferrostatin-1 Efficacy: Ferrostatin-1 treatment significantly alleviated NP-induced colon inflammation and immune cell infiltration.
  • YAP Inhibitor Efficacy: VTPF treatment significantly reduced inflammation and restored intestinal parameters in mice exposed to 10 µm MPs.
  • Fosl1 Knockdown: Knockdown of Fosl1 mitigated NP-induced ferroptosis and mitochondrial damage.
  • YAP Knockdown: Knockdown of YAP partially alleviated microplastic-induced mechanical damage and metabolic changes.

Limitations and Future Work

  • Single Polymer Type: The study primarily focused on polystyrene (PS) microplastics. Future research should investigate other common plastic types (e.g., polyethylene, polypropylene) and their synergistic effects.
  • Limited Particle Sizes: While the study focused on 100 nm and 10 µm as representative sizes, a broader range of particle sizes could provide a more comprehensive understanding.
  • Gut Microbiome: The impact of microplastics on the gut microbiome and its role in intestinal damage was not extensively investigated and is suggested as a future research direction.
  • Low-Dose, Long-Term Exposure: While the study used relevant exposure concentrations, exploring sub-toxic, long-term exposure scenarios would better mimic chronic human exposure.
  • Immunogenic Cell Death (ICD) Confirmation: While strong evidence for ferroptosis-mediated immune activation was shown, definitive diagnosis of ICD would require assessment of specific DAMPs (e.g., CRT, HMGB1, extracellular ATP).
  • Clinical Translation: The proposed therapeutic strategies require extensive preclinical and clinical validation for translation to human health.

Summary updated

Abstract

This study investigates the size-dependent mechanisms by which polystyrene (PS) microplastics (MPs) cause intestinal epithelial injury, focusing on the differential effects of nanoscale (100 nm) and microscale (10 μm) particles. Using both cellular and animal models, we found that 100 nm MPs are internalized by intestinal epithelial cells via endocytosis, triggering oxidative stress and ferroptosis, while 10 μm MPs primarily induce epithelial damage through mechanical disruption and metabolic reprogramming. Proteomic analyses revealed that small MPs significantly upregulate ferroptosis-related genes, including Fosl1 and components of the p53 pathway. Functional studies showed that Fosl1 promotes p53 transcription, suppresses Slc7a11, and contributes to ferroptosis. Mechanistically, ferroptosis was characterized by intracellular iron accumulation, glutathione (GSH) depletion, GPX4 inactivation, and excessive lipid peroxidation. Treatment with Ferrostatin-1 or Fosl1 knockdown alleviated ferroptosis and epithelial injury. In contrast, large MPs activated the mechanosensitive YAP pathway, leading to cytoskeletal remodeling and a metabolic shift from oxidative phosphorylation to anaerobic glycolysis. This metabolic reprogramming was associated with increased inflammation. These findings demonstrate that microplastic particle size critically determines toxicity mechanisms—ferroptosis for small particles and YAP-mediated metabolic disruption for large ones—and suggest potential therapeutic targets for mitigating microplastic-induced intestinal damage.
BibTeX
@article{cheng2025molecular,
  author = {Yixian Cheng and Junjie Chen and Rui Fu and Peng Zhang and Haosong Chen and Haikun Cao and Zilong Jiang and Yuan Hong and Yifan Li and Cuiqi He and Tao Feng and Ting Li and Jiawei Zhang and Bo Chen and Guodong Cao},
  title = {{Molecular mechanism differences between nanoplastics and microplastics in colon toxicity: nanoplastics induce ferroptosis-mediated immunogenic cell death, while microplastics cause cell metabolic reprogramming}},
  journal = {Journal of Nanobiotechnology},
  year = {2025},
  doi = {10.1186/s12951-025-03545-1},
}
Figure